0 — Class II drug recall D-1240-2015
Terminated recall by Hospira Inc., reported 2015-07-22. Lack of assurance of sterility: Potential channel leaks near the threaded vial port.
| Recall number | D-1240-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., Lake Forest, IL, United States |
| Recall initiated | 2015-07-02 |
| Classified | 2015-07-15 |
| Reported by FDA | 2015-07-22 |
| Terminated | 2016-11-17 |
| Quantity | 314,600 bags |
| Reason classes | sterility, packaging |
| NDC | 00409-7101-68 |
| Lot numbers | 49-084-JT, 49-119-JT |
Product
0.9% Sodium Chloride Injection USP, 50 mL ADD-Vantage Unit, Rx only, Manufactured by Hospira, Inc., Ausitn, TX 78728, NDC 00409-7101-68
Reason for recall
Lack of assurance of sterility: Potential channel leaks near the threaded vial port.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1240-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.